8,000
Clinical Samples
Analyzed
66
Hospital
Partnerships
12
Pending
Patents
David Zhang
Co-Founder/CEO
Co-Founder, NuProbe Global (2017-2023); CEO, NuProbe USA (2021-2023)
Raised over $110M of venture capital (inc. Sequoia China and AstraZeneca), achieved $21M revenue in 2022.
Led business partnerships with Bio-Rad, Adaptive Biotechnology, Gilead, Epizyme, Cepheid, and Oxford Nanopore.
Collaborated with clinicians from MD Anderson, Yale School of Medicine, Mayo Clinic, and BCM.
Associate Professor of Bioengineering, Rice University (2013-2021)
60+ peer-reviewed publications, including in Science, Cancer Discovery, Blood, Nature Biomedical Engineering, Nature Methods, Nature Chemistry.
https://scholar.google.com/citations?hl=en&user=q3sWmXUAAAAJ
Assistant Professor of Mechanical Engineering, MIT (2020-2024)
30+ peer-reviewed publications, including in NeurIPS\, Nature, Science, PNAS.
https://scholar.google.com/citations?hl=en&user=Q3kRJj4AAAAJ
Co-Founder and CTO, Palamedrix (2020-2022)
Raised $6M of venture funding, acquired by Somalogic for $50M+ in 2022.
Research Fellow, Google X (2017-2019)
Longitudinal medical imaging AI for detecting melanoma
Paul Rothemund
Ph.D. | VP of Research
Co-founder and CSO, Palamedrix
(2020-2024)
Research Professor, Caltech (2008-2023)
MacArthur Fellow, 2007
CFO, Torus Biosystems (2022-2023)
VP Finance, Proven Skincare (2020-2022)
Head of FP&A, Genuity / Wuxi Apptec (2018-2020)
Chief Medical Officer, Biomerieux
(2021-2023)
Chief Medical Officer, Roche (2013-2020)
Timothy Kassis
Ph.D. | Head of AI
Head of AI and Data, Matterworks
(2021-2025)
Instructor, MIT (2017-2021)
Sr. Scientist, Nuprobe (2020-2024)
Inventor on 12 patents
Director of Bus. Dev, Nuprobe (2018-2023)
Bus. Dev. Fellow, Harvard Medical School (2015-2017)
Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise - you are buying a piece of a company and helping it grow.
Accredited investors can invest as much as they want. But if you are NOT an accredited investor, your investment limit depends on either your annual income or net worth, whichever is greater. If the number is less than $124,000, you can only invest 5% of it. If both are greater than $124,000 then your investment limit is 10%.
To calculate your net worth, just add up all of your assets and subtract all of your liabilities (excluding the value of the person’s primary residence). The resulting sum is your net worth.
We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.
Individuals over 18 years of age can invest.
No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted, and no part of the purchase price can be received until the offering statement is filed and only through an intermediary’s platform. An indication of interest involves no obligation or commitment of any kind. "Reserving" securities is simply an indication of interest.